Brain imaging in cerebellar ataxia associated with autoimmune polyglandular syndrome type 2

Journal of Neuroimaging

Volumn 22, Issue 3, 2012, Pages 308-311

  Manto, Mario ^a   Jissendi, P ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

APS type 2; Ataxia; Autoimmune; Brain imaging; Cerebellum; Schmidt syndrome

Indexed keywords

CREATINE; N ACETYLASPARTIC ACID;

ADRENAL INSUFFICIENCY; ADULT; ARTICLE; AUTOIMMUNE POLYGLANDULAR SYNDROME TYPE 2; AUTOIMMUNE THYROIDITIS; CASE REPORT; CEREBELLAR ATAXIA; CEREBELLUM ATROPHY; GOITER; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

ADULT; BRAIN; CEREBELLAR ATAXIA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; POLYENDOCRINOPATHIES, AUTOIMMUNE;

EID: 84863769017     PISSN: 10512284     EISSN: 15526569     Source Type: Journal    
DOI: 10.1111/j.1552-6569.2010.00542.x     Document Type: Article

References (19)

1. Eisenbarth GS, Gottlieb PA. Autoimmune polyendocrine syndromes. N Engl J Med 2004;350:2068-2079.
2. Betterle C, Dal Pra C, Mantero F, et al. Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction. Endocr Rev 2002;23:327-364.
3. Majeroni BA, Patel P. Autoimmune polyglandular syndrome, type II. Am Fam Physician 2007;75:667-670.
4. Falorni A, Laureti S, Santeusanio F. Autoantibodies in autoimmune polyendocrine syndrome type II. Endocrinol Metab Clin North Am 2002;31:369-389.
5. Betterle C, Lazzarotto F, Presotto F. Autoimmune polyglandular syndrome Type 2: the tip of an iceberg? Clin Exp Immunol 2004;137:225-233.
6. Hadjivassiliou M, Sanders DS, Woodroofe N, et al. Gluten ataxia. Cerebellum 2008;7(3):494-498.
7. Trouillas P, Takayanagi T, Hallett M, et al. International cooperative ataxia rating scale for pharmacological assessment of the cerebellar syndrome. J Neurol Sci 1997;145:205-211.
8. Berger JR, Weaver A, Greenlee J. Neurologic consequences of autoimmune polyglandular syndrome type 1. Neurology 2008;70:2248-2251.
9. Boz C, Velioglu S, Altunayoglu V, et al. Central nervous system involvement in autoimmune polyglandular syndrome. Clin Neurol Neurosurg 2003;105(2):102-104.
10. Karmon Y, Inbar E, Cordoba M, et al. Paraneoplastic cerebellar degeneration mimicking acute post-infectious cerebellitis. Cerebellum 2009;8(4):441-444.
11. Manto M. Cerebellar Disorders: A Practical Approach to Diagnosis and Management. Cambridge, UK : Cambridge University Press, 2010.
12. Seissler J, Bieg S, Yassin N, et al. Association between antibodies to the MR 67, 000 isoform of glutamate decarboxylase (GAD) and type 1 (insulin-dependent) diabetes mellitus with coexisting autoimmune polyendocrine syndrome type II. Autoimmunity 1994;19:231-238.
13. Abele M, Weller M, Mescheriakov S, et al. Cerebellar ataxia with glutamic acid decarboxylase autoantibodies. Neurology 1999;52:857.
14. Lauria G, Pareyson D, Pitzolu MG, et al. Excellent response to steroid treatment in anti-GAD cerebellar ataxia. Lancet Neurol 2003;2:634-635.
15. Saiz A, Arpa J, Sagasta A, et al. Autoantibodies to glutamic acid decarboxylase in three patients with cerebellar ataxia, late-onset insulin-dependent diabetes mellitus, and polyendocrine autoimmunity. Neurology 1997;49:1026-1030.
16. Honnorat J, Saiz A, Giometto B, et al. Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies: study of 14 patients. Arch Neurol 2001;58:225-230.
17. Fujioka M, Okuchi K, Hiramatsu KI, et al. Specific changes in human brain after hypoglycemic injury. Stroke 1997;28:584-587.
18. Kim DE, Park SH, Kim SK, et al. Hypoglycemia-induced cerebellar dysfunction and quantitative positron emission tomography study. Neurology 2000;55:418-422.
19. Heikkilä O, Mäkimattila S, Timonen M, et al. Cerebellar glucose during fasting and acute hyperglycemia in nondiabetic men and in men with type 1 diabetes. Cerebellum 2010;9:336-344.